TransMedics Group, Inc. (TMDX) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-04 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: TransMedics Group, Inc. (TMDX) CIK: 0001756262 --- Reporting Owner --- Name: Weill David CIK: 0001774270 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-04 | Code: M (Exercise of derivative) Shares: +3,571 | Price: $14.20 Total Value: $50,708.20 Shares Owned After: 15,705 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-03-04 | Code: S (Open market sale) Shares: -3,571 | Price: $146.82 Total Value: $524,294.22 Shares Owned After: 12,134 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-03-04 | Code: M (Exercise of derivative) Shares: -3,571 | Price: $0.00 Exercisable: N/A | Expires: 2030-06-04 Shares Owned After: 1,429 | Ownership: D (Direct) Footnotes: [F1] The option is fully vested. --- Footnotes (Complete Index) --- F1: The option is fully vested. --- Signature --- /s/ By: /s/ Gerardo Hernandez, Attorney-in-Fact (2026-03-06)